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Abstract: Unlike nuclear nucleolin, surface-expressed and cytoplasmic 
nucleolin exhibit Tn antigen. Here, we show localization-dependent differences 
in the glycosylation and proteolysis patterns of nucleolin. Our results provide 
evidence for different paths of nucleolin proteolysis in the nucleus, in the 
cytoplasm, and on the cell surface. We found that full-length nucleolin and some 
proteolytic fragments coexist within live cells and are not solely the result of the 
preparation procedure. Extranuclear nucleolin undergoes N- and O-glycosylation, 
and unlike cytoplasmic nucleolin, membrane-associated nucleolin is not 
fucosylated. Here, we show for the first time that nucleolin and endogenous 
galectin-3 exist in the same complexes in the nucleolus, the cytoplasm, and on 
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the cell surface of melanoma cells. Assessments of the interaction of nucleolin 
with galectin-3 revealed nucleolar co-localization in interphase, suggesting that 
galectin-3 may be involved in DNA organization and ribosome biogenesis.  
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Nucleolin is a ubiquitous non-histone nucleolar phosphoprotein shown to be 
overexpressed in rapidly dividing cells and cancer cell lines [1–3]. It is  
a multifunctional protein involved in numerous cell processes, such as 
proliferation and growth, transcription, cytokinesis, nucleogenesis, signal 
transduction, mRNA regulation, apoptosis, induction of chromatin condensation, 
and replication [4].  
Nucleolin is composed of three main domains. There is the N-terminal domain, 
which is rich in acidic residues and is the site of numerous phosphorylations by 
casein kinase 2 (CK2) and cyclin dependent kinase 1 (CDK1). It is also the site 
where the bipartite nuclear localization signal (NLS) is localized. The central 
domain contains four RNA recognition motifs (RBDs) that are determinants of 
RNA-binding specificity. Finally, there is the C-terminal domain, which is rich 
in arginine and glycine residues (RGG or GAR domain) that participate in 
interactions with ribosomal proteins [5, 6]. This domain exhibits helicase 
activity, and contributes to non-specific RNA binding [7]. As a nucleolar 
protein, it is usually found in dense fibrillar components (DFC) and granular 
components (GC) of nucleoli, where it participates in multiple stages of early 
pre-rRNA processing, such as rDNA transcription, pre-rRNA processing, and 
assembly of ribosomal proteins and rRNAs [6, 8]. Phosphorylation of nucleolin 
by CK2 is important in the regulation of rDNA transcription [9, 10].  
In the nucleoplasm, nucleolin has been found associated with several genes 
transcribed by Pol II. It is involved in many aspects of gene expression, 
including chromatin remodeling, DNA recombination and replication, gene 
transcription, and regulation of the telomerase [4, 11].  
Despite the lack of an export signal, nucleolin shuttles to the cytoplasm, where it 
takes part in regulation of translation and mRNA stability [12–17]. In some 
cancer cells where nucleolin is overexpressed in the cytoplasm, aberrant 
stabilization by nucleolin leads to upregulation of the anti-apoptotic Bcl-2 
protein, elevating resistance to chemotherapy and helping cancer cells avoid 
apoptosis [18, 19]. Cytosolic nucleolin also has been shown to suppress the 
translation and induction of p53 after DNA damage [20], thereby facilitating the 
generation of viable genetically altered cells and possibly leading to malignancy. 
Shuttling of nucleolin between the nucleus and cytoplasm supports the import 
and/or export of several nucleolar components or proteins, such as ribosomal 
proteins.  
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Although nucleolin lacks a transmembrane domain or signal sequence, a large 
number of reports have identified nucleolin on the cell membrane [21–28] in 
close association with the intracellular actin cytoskeleton. Upon stimulation of 
cell proliferation, cytoplasmic nucleolin is translocated to the surface [29]. Cell 
surface nucleolin serves as a receptor, with potential roles in cell migration and 
adhesion and in virus infection [30]. Cell surface nucleolin is a receptor for 
gp120 of HIV-1 [21], intimin-gamma of enterohemorrhagic Escherichia coli 
O157-H7, various growth factors, such as midkine, pleiotrophin and lactoferrin 
[27, 31, 32], DNA aptamers [18], and DNA nanoparticles. It may be a key 
transporter for all of these compounds from the membrane through the 
cytoplasm to the nucleus [23]. Nucleolin has been reported as a ligand for L- and 
P-selectins [25, 33]. It acts as the polylactosaminoglycan-binding receptor on 
macrophages [34] and as a endostatin receptor that mediates the anti-angiogenic 
and antitumor activities of endostatin [35]. Plasma membrane nucleolin has been 
reported to act as a binding molecule for agents involved in proliferation, such as 
the tumor-homing peptide F3 in the endothelial cells of angiogenic blood vessels 
[24]. Therefore, the protein has been indicated as a shuttle molecule between the 
cell surface and nucleus, and indeed as a mediator for extracellular regulation of 
nuclear activity [11]. Prediction of MHC class-I binding sites in nucleolin may 
make it a potential target for T-cells and thus a candidate for immunotherapy [28].  
It was recently demonstrated that nucleolin undergoes complex N- and  
O-glycosylation [28, 36–38]. Two N-glycosylation sites localized in the RBD 1 and 
3 domains were defined, and five potential O-glycosylation sites in the  
N-terminal domain were predicted [36]. The presence of O-glycans was 
confirmed by the presence of T and Tn antigen and fucosyl-containing O-glycan 
chains. Since extranuclear nucleolin differs from the nuclear form by its 
glycosylation, it was hypothesized that glycosylation may help to regulate 
nucleolin traffic, functions and degradation [36, 39].  
Interestingly, there are conspicuous functional similarities between nucleolin and 
galectin-3. Both proteins contain a nuclear localization signal but lack a signal 
sequence. They are localized on the cell surface and in intracellular spaces 
(cytoplasm and nuclear matrix), and they shuttle between the nucleus and 
cytoplasm. Both nucleolin and galectin-3 are secreted via a non-classical 
pathway. Both proteins are multifunctional molecules. Numerous proteins are 
capable of interacting with nucleolin or galectin-3. Like nucleolin, galectin-3 is 
able to bind DNA and RNA [40], and in the nucleus galectin-3 acts as a pre-
mRNA splicing factor [41]. In this study, we sought to assess the glycosylation 
profiles of nucleolin from membrane, cytoplasmic and nuclear fractions. In view 
of the similar distributions of nucleolin and galectin-3 in the cell, we also 
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MATERIALS AND METHODS 
 
Materials 
Biotinylated, FITC-conjugated and agarose-bound lectins, and Vectashield 
Hardset mounting medium with DAPI were purchased from Vector. Anti-mouse 
IgG/AP, anti-rabbit IgG/AP and rabbit anti-histone H2B polyclonal antibody 
were from Chemicon. Immunoprecipitation Kit (Protein G) was purchased from 
Roche. Mouse anti-human L1CAM mAbs, clone UJ127.11, RPMI 1640 with 
GlutaMax-I medium (Gibco), foetal bovine serum (Gibco), Protein Assay Kit, 
ExtrAvidin/AP, normal goat serum and protease inhibitor cocktail were obtained 
from Sigma. Mouse anti-human nucleolin mAbs MS-3, mouse anti-human 
nucleolin mAbs D-6, mouse anti-Galectin-3 mAbs (clone A3A12) and mouse 
anti-Galectin-3 mAbs (clone 9C4) were from Santa Cruz Biotechnology. Alexa 
Fluor Cy3-conjugated goat anti-mouse mAbs, goat anti-mouse  
IgG-AlexaFluor488 and StreptAvidin-AlexaFluor488 were from Invitrogen. 
Anti-β-tubulin was purchased from Pharmingen. Trypsin was from Biocentrum. 
ProteoExtract Subcellular Proteome Extraction Kit was from Calbiochem 
(Merck Millipore). All other chemicals were of the highest purity and were 
purchased from Sigma-Aldrich.  
 
Cell lines and cell culture conditions 
The metastatic melanoma cell line Ma-Mel-27 was donated by Professor  
D. Schadendorf of the Klinik für Dermatologie, Venerologie und Allergologie of 
the Universitätsklinikum Essen in Germany. Mycoplasma free cells were 
maintained in RPMI 1640 medium with GlutaMax-I, supplemented with 10% 
foetal calf serum, 100 units/ml penicillin and 100 μg/ml streptomycin. Cells 
were grown in monolayers in a 95% air/5% CO2 atmosphere at 37ºC in  
a humidified incubator. Mycoplasma infection of the cell culture was verified 
using commercial PCR testing and confocal microscopy. 
 
Cell extract preparation 
The whole cell protein extract was prepared on ice by sonication (Bandelin 
Electronic) of cells in a buffer consisting of 50 mM Tris/HCl (pH 7.5), 1 mM 
EDTA, protease inhibitor cocktail (20 µl/ml) and 1 mM phenylmethylsulfonyl 
fluoride, and then Triton X-100 (final concentration 1%) and protamine sulfate 
(final concentration 0.3%) were added. The homogenates were incubated for 30 min 
with shaking on ice. The cell extracts were clarified by centrifugation at 18,000 x g 
for 20 min at 4ºC. The protein concentrations were determined using a Protein 
Assay Kit. 
For fresh cell extract preparation, Ma-Mel-27 cells were grown until they reach 
80% confluence in 30-mm culture dish. The cells were then washed twice with 
cold PBS, scraped with a rubber policeman and treated with 75 µl of boiling  
2 x Laemmli buffer contained 2 mM EDTA and 10% β-mercaptoethanol. The 
sample was heated for 10 min at 100ºC and then 15 µl of sample was loaded into 
a polyacrylamide gel electrophoresis well. 
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Subcellular fractionation was done using ProteoExtract Subcellular Proteome 
Extraction Kit according to the manufacturer’s instruction. Each fraction was 
desalted via MeOH/CHCl3 precipitation and subjected to 10% sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). After electrotransfer 
on a PVDF membrane, immunodetection of nucleolin was performed using 
mAbs MS-3 (1:6000 dilution). Proteins specific to each fraction were detected 
using antibodies against L1CAM (mAbs UJ127.11; 1:12500 dilution) for the 
membrane fraction; tubulin (mAbs anti-tubulin; 1,5:1000 dilution) for the 
cytosolic fraction; and H2B (pAbs anti-Histone H2B; 1:1000 dilution) for the 
nuclear fraction. Suitable anti-mouse IgG/AP (1:4000 dilution) or anti-rabbit 
IgG/AP (1:4000) were used as secondary antibodies. The conjugated alkaline 
phosphatase was detected via NBT/X-phosphate staining.  
 
Lectin precipitation and western blotting 
Whole cell extract (300 µg of total protein) was diluted with an incubation 
buffer consisting of 10 mM HEPES, 150 mM NaCl, 0.1 mM CaCl2, 0.01 mM 
MgCl2 (pH 7.5) at a 1:1 (v/v) cell extract to buffer ratio, and incubated overnight 
at 4ºC with 5 l of biotinylated lectins or with 40 l of agarose-bound lectins. 
Afterwards, the samples with biotinylated lectins were mixed with 30 l of 
Streptavidin-agarose for additional 4 h at 4ºC. All of the precipitates were 
washed three times with incubation buffer, and once with PBS with subsequent 
centrifugations (1500 rpm, 3 min). Precipitated glycoproteins were liberated by 
boiling in 2 x Laemmli buffer containing 10% β-mercaptoethanol and 2 mM EDTA 
at 100ºC for 8 min.  
In parallel, negative controls were created using lectins preincubated with 0.4 M acetic 
acid (2 h, RT), and then incubated with whole cell extract (final concentration of 
acetic acid: 0.2 M). Electrophoresis in 10% SDS-PAGE, electrotransfer onto 
PVDF membrane and immunodetection of nucleolin using anti-nucleolin mAbs 
(D-6; 1:3000 dilution) were performed. Rabbit anti-mouse IgG/AP (1:4000 
dilution) was used as a secondary antibody and the conjugated alkaline 
phosphatase was detected via NBT/X-phosphate staining. 
 
Reciprocal co-immunoprecipitation and western blotting 
Subcellular extracts (300–700 l) that contained proteins in their native state were 
immunoprecipitated with anti-nucleolin mAbs (D-6; 1.2–2 g) or with anti-
galectin-3 mAbs (9C4; 2–2.5 g) for 18 h at 4ºC. Subsequently, 30 l of Protein  
G-agarose (Immunoprecipitation Kit) was added to each of the immunoprecipitates 
and incubated for additional 7 h at 4ºC. The beads were washed three times in 1 ml 
PBS containing 1 mM CaCl2 and 1 mM MgCl2, and then the bound proteins were 
eluted by boiling in 2 x Laemmli buffer containing 10% β-mercaptoethanol, 2 mM 
EDTA at 100ºC for 8 min. Electrophoresis and western blotting were performed as 
described above. Immunodetection of galectin-3 on blot was performed using the 
mouse monoclonal anti-galectin-3 antibody (9C4; 1:1000 dilution). 
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Protein identification by mass spectrometry (MS) based on peptide sequencing 
Sample preparation and MS measurements 
We used lectin precipitation for nucleolin isolation, because the IgG heavy 
chains of anti-nucleolin co-migrate in SDS-PAGE with some proteolytic 
fragments of nucleolin. Protein bands of interest, corresponding to VVA-positive 
protein bands, were excised from the SDS-PAGE gel and chopped into cubes 
(ca. 1 mm x 1 mm). The obtained pieces were destained by washing several 
times in 25% and 50% acetonitrile, reduced at 56ºC for 45 min in 50 mM DTT 
and alkylated for 2 h at room temperature in darkness using 55 mM 
iodoacetamide. Excess reagents were washed out with 50% acetonitrile in 
ammonium bicarbonate buffer and gel pieces were dried in 100% acetonitrile 
followed by drying for 15 min in SpeedVac. After that, gel pieces were 
subjected to in-gel digestion with 15 µl 10 ng/µl trypsin solution. Digestion was 
carried out at 37ºC overnight. The peptides were extracted from the gel by 
sonication. The extracts were evaporated until dry and resuspended in 2% ACN 
with 0.05% TFA. The resulting peptide mixtures were analyzed using UltiMate 
3000RS LCnanoSystem (Dionex) coupled with MicrOTOF-Q II mass 
spectrometer (Bruker) using Appollo Source ESI nano-sprayer equipped with 
low-flow nebulizer. The peptides were injected on a RP-C18 precolumn 
(Acclaim PepMap Nano trap Column) using 2% ACN with 0.05% TFA as  
a mobile phase, and further separated on a 15 cm × 75 µm RP column (Acclaim 
PepMap 100 µm 100 Å Nano Series TM Column) using a gradient 2–40%  
ACN in 0.05% FA for 60 min. Each peptide separation was preceded by a blank 
run to ensure the absence of cross-contamination. Mass spectrometry was 
operated in standard DDA (data dependent acquisition) MS/MS mode with 
fragmentation of the most intensive precursor ions. 
 
Analysis of mass spectrometry data 
Mascot Generic format (.mgf) file was generated by preprocessing the raw data 
with Data Analysis 4.0 software (Bruker). The obtained peak lists were used to 
search the non-redundant protein database of the SwissProt and NCBI (with the 
taxonomy restriction: Homo sapiens – 20,257 sequences) using in-house Mascot 
server (v.2.3.0, Matrix Science). The following search parameters were applied:  
Enzyme specificity – trypsin 
Permitted number of missed cleavages – 1 or 2 
Fixed modification – carbamidomethylation (C) 
Variable modifications – oxidation (M) 
Protein mass – unrestricted 
Peptide mass tolerance – ± 20 ppm 
Fragment mass tolerance – ± 0.05 Da 
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Immunofluorescence and confocal microscopy  
Cells were prepared for confocal microscopy according to Hoja-Łukowicz 2009 
et al. [28] and examined using a LSM 510 META, Axiovert 200 M, ConfoCor 3 
confocal microscope (Carl Zeiss MicroImaging). FITC-conjugated lectins 
(dilution 1:200) or biotin-labelled lectins (1:300 dilution): GNA, DSA, LEA, 
PHA-E, PHA-L, MAA-II, SNA-I, AAA, UEA-I, LTA and PNA were used for 
co-localization studies. In case of biotinylated lectins additional incubation with 
StreptAvidin-AlexaFluor488 (1:300 dilution) was performed. In the controls, 
lectins pre-blocked with the corresponding hapten or with 0.2 M acetic acid (2 h, RT) 
were used (Table 1). In additional control, lectin incubation was omitted to 
reveal non-specific staining due to StreptAvidin binding.  
Galectin-3 was stained with mouse monoclonal anti-Galectin-3 for 2 h (clone 
A3A12; 1:100 dilution in 2% BSA/PBS), and then with anti-mouse  
IgG-AlexaFluor488 (dilution 1:100 in 2% BSA/PBS) for additional 2 hrs. The 
quantitative analysis of co-localization was performed using profile display 
mode (LSM image browser, Zeiss, Oberkochen, Germany) and the intensity 
profile graphs were drawn.  
 
Table 1. Lectins used in fluorescence staining and their inhibitory compounds. 
 
Lectin Composition of blocking solution 
GNA 0.5 M methyl α-D- mannopyranoside in 1% BSA/PBS 
DSA 0.5 M D(+)glucosamine hydrochloride in 1% BSA/PBS 
LEA 0.5 M D(+)glucosamine hydrochloride in 1% BSA/PBS 
PHA-E 1 M N-Acetyl-D-galactosamine in 1% BSA/PBS 
PHA-L 1 M N-Acetyl-D-galactosamine in 1% BSA/PBS 
MAA glycophorin A (1mg/ml) in PBS 
SNA-I 0.2 M CH3COOH in 1% BSA/PBS 
AAA 0.5 M L(-)fucose in 1% BSA/PBS 
LTA 0.5 M L(-)fucose in 1% BSA/PBS 
UEA-I 0.5 M L(-)fucose in 1% BSA/PBS 
PNA 0.5 M D(+)galactose in 1% BSA/PBS 
 




Subcellular localization of nucleolin in melanoma cells 
Human melanoma Ma-Mel-27 cells were fractionated into cytosolic, membrane 
and nuclear fractions, each of which was subjected to SDS-PAGE and further 
immunoblotted with anti-nucleolin antibody (Fig. 1A). The molecular mass of 
nucleolin is predicted to be 77 kDa, but nucleolin is known to migrate in SDS-PAGE 
as a ~105-kDa protein band (instead of 77 kDa), because of the presence of very 
large acidic amino acid clusters in its N-terminal domain. These impede correct 
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binding of SDS on the protein [5]. We observed a 107-kDa band corresponding 
to the full-length form of nucleolin. We found many degradation fragments with 
molecular weights below 107 kDa. To check whether the observed degradation 
fragments resulted from autoproteolysis of nucleolin or from the isolation and 
extraction procedures, we prepared fresh whole cell extract by directly treating  
a cell culture monolayer with boiling Laemmli sample buffer. The 
immunodetected peptide bands of 107, 98, 89, 85, 59 (weak band), 55 and  
49 (weak band) kDa (Fig. 1B), supported the coexistence of untruncated and 
truncated forms of nucleolin within live cells. This is in accord with the well-
known instability and self-cleaving activity of nucleolin, even in the presence of 
added protease inhibitors [42, 43].  
On the other hand, the presence of additional bands in the membrane (72, 68, 53, 
46 kDa) and nuclear (72, 68, 53 kDa) fractions along with the disappearance of 
the full-length form in the membrane fraction (Fig. 1A) result from degradation 




Fig. 1. Nucleolin expression in Ma-Mel-27 cells. A – Subcellular localization of nucleolin 
analyzed in cell fractions. Cells were fractionated into cytosolic (1), membrane (2) and nuclear 
(3) fractions with the ProteoExtract Subcellular Proteome Extraction Kit, and each fraction was 
immunoblotted with anti-nucleolin antibody. B – Nucleolin detection in freshly prepared cell 
extract. Fresh whole cell extract was prepared by directly treating a cell culture monolayer with 
boiling Laemmli sample buffer and then electrophoresed. Nucleolin was analyzed by 
immunoblotting. C – Determination of subcellular fraction purity. The purity of isolated 
subcellular fractions was confirmed by western blotting with antibodies for fraction-marker 
proteins: L1CAM for cell membrane (2), β-tubulin for cytosol (1), and H2B for nuclei (3). 
Peptide bands were visualized using AP-conjugated secondary antibody with subsequent 
colorimetric detection. Molecular masses (kDa) are indicated on the left-hand side of the blots. 
 
In this case, the proteolytic degradation pattern of nucleolin was specific to the 
particular cell compartment. The nucleolin in the cytosolic fraction was the least 
degraded. We found a much stronger signal for higher molecular weight 
polypeptides for cytoplasmic (107 kDa and 85 kDa) or nuclear nucleolin (98 
kDa and 85 kDa) than for membrane-associated nucleolin (Fig. 1A). However, 
there were two additional bands at positions of 89 kDa and 46 kDa in the 
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membrane fraction (Fig. 1A, line 2). Moreover, in both cytosolic and nuclear 
fractions there was one additional band at 59 kDa. The identity and purity of 
each fraction were monitored by immunodetection of tubulin (cytosol-positive 
control), L1CAM (membrane-positive control) and histone H2B (nuclear-
positive control) (Fig. 1C). Histone H2B was detected exclusively in the nuclear 
fraction, demonstrating that the nucleolin detected in the cytosolic and 
membrane fractions was not due to nuclear contamination. L1CAM was 
expressed at high levels in the membrane fraction. The lack of immunodetected 
tubulin in the membrane and nuclear fractions supports the purity of all the 
subcellular fractions. 
 
Lectin reactivity of nucleolin in melanoma cells 
To examine the glycosylation profile of nucleolin, we used a set of lectins for 
lectin precipitation and confocal microscopy analysis. Lectin precipitation 
followed by on-blot immunodetection of nucleolin showed a lectin-dependent 
pattern of bands corresponding to the particular proteolytic degradation 
fragments of nucleolin (Fig. 2). The 46-kDa band showed no glycosylation for 
the lectin probes we used. Moreover, no 89- or 85-kDa bands were observed in 




Fig. 2. Western blot analysis of nucleolin glycosylation. Immunodetection of nucleolin in 
whole-cell extract from cell line Ma-Mel-27 (Immuno), in lectin precipitates, and in a control 
sample obtained by precipitation with preinhibited lectin (Control). Lectin abbreviations and 
binding specificities: GNA, Galanthus nivalis agglutinin (recognizes high mannose and 
hybrid type oligosaccharides); DSA, Datura stramonium agglutinin (recognizes two or three 
N-acetyllactosaminyl repeats); LEA, Lycopersicon esculentum agglutinin (recognizes three or 
more N-acetyllactosaminyl repeats); PHA-L, Phaseolus vulgaris leucoagglutinin (recognizes 
GlcNAcβ1-6-branched triantennary and tetraantennary complex type glycans); PHA-E, 
Phaseolus vulgaris erythroagglutinin (recognizes bisecting GlcNAc residue); MAA-II, 
Maakia amurensis agglutinin (recognizes sialic acid α2-3-bound to terminal galactose 
residue); SNA-I, Sambucus nigra agglutinin (tetramer; recognizes sialic acid α2-6-bound to 
terminal galactose or to N-acetylgalactosamine); AAA, Aleuria aurantia agglutinin 
(recognizes fucose residues); UEA-I, Ulex europaeus I agglutinin (recognizes α1-2-bound to 
terminal galactose residue). The molecular masses (kDa) of full-length nucleolin and its 
proteolytic fragments are indicated on the left-hand side of the figure. 
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The GNA-positive bands confirmed the presence of high mannose or high 
mannose and hybrid-type oligosaccharides. The DSA-positive bands confirmed 
the presence of N-acetyllactosamine species with two or three  
N-acetyllactosaminyl repeats attached to C-2 and 6 of α-mannose on the C-6 
side. The LEA-positive bands suggest the presence of poly-N-acetyllactosamine 
units [44]. The PHA-E- and PHA-L-positive bands confirmed the presence of 
bisected complex N-glycans and the presence of GlcNAcβ1-6-branched 
triantennary and/or tetraantennary complex-type glycans respectively. The 
reactivity of nucleolin with MAA-II and SNA-I respectively showed the presence 
of α2-3- and α2-6-linked sialic acids in nucleolin. We used AAA, LTA and UEA-
I lectins to disclose the presence of fucose and monosaccharide residues to 
which fucose had been bound. All these lectins recognize L-fucosyl residues but 
AAA binds Fucα1-6 linked to the proximal GlcNAc residue (core fucose) as 
well as the Fucα1-2Galβ1-4GlcNAc sequence (blood group H(0) determinant) 
and the Galβ1-4(Fucα1-3)GlcNAc sequence (Lex determinant). LTA and UEA-I 
are reported to prefer Lex/H and H determinant respectively, but terminal  
α2-3-sialylation of Lex structure limits LTA binding [45]. The presence of  
O-linked glycans was detected using VVA lectin (recognizes GalNAc  
α-O-Ser/Thr; Tn antigen) and PNA lectin (recognizes Galβ1-3GalNAcα-O-
Ser/Thr; T antigen).  
Since preincubation of lectins with appropriate haptenic sugars before lectin 
precipitation did not block the binding sites of lectins, even when the sugar 
concentration was elevated up to 20 times in comparison with the concentration 
recommended by the supplier (data not shown), we used 0.4 M acetic acid to 
inhibit the binding sites of lectins. Almost total inhibition was observed in the 
case of all of the lectins. Note that the intensity of the 49-kDa band, despite its 
presence in the control, was significantly weaker in comparison with the same 
band in each lectin-positive probe (a typical control sample is shown in Fig. 2 
Control). It could mean that this part of the bound lectin, namely, the part that 
does not bind in the presence of acetic acid, is bound to specific sugar residues, 
and another part, the part that binds in the presence of acetic acid, is bound 
nonspecifically to nucleolin. To confirm that the observed degradation fragments 
were of nucleolin origin, VVA-agarose precipitated and CBB-stained protein 
bands, which corresponded to nucleolin bands in western blot, were excised 
from the gel and subjected to nanoLC-MS/MS analysis (Fig. 3A). Protein 
identification based on peptide sequence analysis in the SwissProt database 
within the Mascot search engine showed the presence of nucleolin in all of the 
studied bands (Fig. 3B). This result also supports the high specificity of the 
antibody. The matched peptides covered between 5.2 and 35.1 % (2–31 peptides) 
of the protein sequence (Suppl. Fig. 1 in Supplementary material at 
http://dx.doi.org/10.2478/s11658-014-0206-4)). In all of the analyzed bands, the 
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Fig. 3. Mass spectrometry analysis of in-gel tryptic digest of full-length nucleolin and 
proteolytic fragments, isolated from total lysate of Ma-Mel-27 cells using VVA-agarose.  
A – The CBB-stained protein bands of interest, isolated by VVA-agarose precipitation 
(shown by arrows; lane 2) and corresponding to western blot-positive protein bands in VVA-
agarose precipitation (line 3) and in whole cell extract (line 4) were excised from the gel and 
subjected to nanoLC-MS/MS analysis. Molecular masses (kDa) of high molecular weight 
markers (line 1) are indicated on the left-hand side of the gel. B – The acquired spectra were 
analyzed using Bruker Data Analysis software and interpreted using Mascot search engine 
against Swiss-Prot and NCBI sequence databases (with the taxonomy restriction: Homo 
sapiens). Peptides determined by sequencing were found to correspond to a high degree of 
certainty to human nucleolin. # Peptide, the number of the identified peptides (based on 
MS/MS spectra); SC[%], the percentage of the protein’s sequence that is represented by the 
identified peptides. 
 
The subcellular co-localization of nucleolin with lectin-positive carbohydrate 
structures in Ma-Mel-27 melanoma cells was assayed by double fluorescence 
(Fig. 4A–C). Nucleolin was localized mainly in the nucleus, although some 
fluorescence was detected in the cytoplasm and on the cell surface. Extranuclear 
nucleolin was more abundant on the cell surface than in the cytoplasm. Lectin 
staining was observed almost exclusively on the cell surface and in the 
cytoplasm (Fig. 4C). Interestingly, the cell surface of Ma-Mel-27 cells was 
UEA-I-negative (data not shown). This result is in agreement with our earlier 
findings on glycosylation of cell surface L1CAM molecules in other human 
melanoma cells [46]. Cells not exposed to lectins showed no obvious fluorescence 
(Suppl. Fig. 2B and D), indicating that the staining observed in cells was not due 
to a nonspecific StreptAvidin binding with cell protein(s). All of the used lectins 
were shown to bind specifically to Ma-Mel-27 cells, as revealed in competitive 
blocking studies with hapten sugars or with the use of 0.2 M acetic acid. Only in the 
case of some blocked lectins was a very weak staining observed (Suppl. Fig. 2).  
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Fig. 4. Confocal microscopy images of doubly labeled Ma-Mel-27 cells in different subcellular 
locations. Cells were cultured in fresh medium for 5 h before labeling. A – Nucleolin detection 
in cytoplasm. Cells were fixed with 3% PFA before simultaneous incubation with mAb MS-3 
(dilution 1:100) and with FITC-labeled lectin (dilution 1:100) or with biotinylated lectin (1:300 
dilution) in 1% BSA/PBS (overnight, RT). B – Detection of cell-surface clustered nucleolin. 
Living unpermeabilized cells were simultaneously incubated with anti-nucleolin mAb MS-3 
(1:25 dilution) and with FITC-labeled lectin (1:100 dilution) or with biotinylated lectin (1:300 
dilution) in 10% NGS, 2% BSA/PBS containing 25 mM NaN3 for 1 h at 37ºC before fixation 
with 2% PFA. C – Nucleolin detection in the nucleus. Cells were fixed with 2% PFA/Triton 
before simultaneous incubation with mAb MS-3 (1:100 dilution) and with FITC-labeled lectin 
(1:100 dilution) or with biotinylated lectin (1:300 dilution) in 1% BSA/PBS (overnight, RT). 
For biotinylated lectins an additional incubation with StreptAvidin-AlexaFluor488 was 
performed. The bound lectin was revealed as green stain. The bound anti-nucleolin antibody 
was revealed using Cy3-labeled goat anti-mouse antibodies (red). Overlapping of the two stains, 
observed as yellow regions (arrows), confirmed the presence of specific glycan residues in 
nucleolin molecules. Nuclei were counterstained with DAPI (blue). The co-localization ratio 
was quantified by measuring the fluorescence intensity overlap with confocal software. Graphs 
depict the intensities (arbitrary units) of signals from nucleolin (red line) and lectin (green line) 
staining between arrowheads in magnified views. White open squares indicate areas magnified 
and shown below. Lectin abbreviations and binding specificities as in Fig. 2. 
 
When the images of cells stained for nucleolin and a given lectin were merged, 
specks of co-localized nucleolin and lectin were seen as scattered dots within the 
cytoplasm and on the cell surface (Fig. 4A and B). No co-localization was observed 
in the nucleoli (Fig. 4C). Overlapping of the two stains, observed as yellow regions, 
confirmed the presence of specific glycan residues in the nucleolin and supported 
the biochemistry results. Interestingly, unlike cytoplasmic nucleolin, membrane-
bound nucleolin was not fucosylated. To quantify the significance of co-localization, 
we analyzed the intensity profile graphs of nucleolin co-localization with a given 
lectin using the profile display mode (LSM image browser, Zeiss). 
 
Galectin-3 co-immunoprecipitates with nucleolin in human melanoma cells 
Since galectin-3 has been shown in different subcellular compartments in malignant 
human cells, and since alterations of the galectin-3 assembly and localization play 
additional roles in cell transformation, we examined whether galectin-3 is a binding 
partner for nucleolin. To determine whether endogenous galectin-3 interacts with 
nucleolin, subcellular extracts from Ma-Mel-27 cells were subjected to 
immunoprecipitation with anti-nucleolin D-6 monoclonal antibody (D-6 is a mouse 
monoclonal antibody raised against amino acids 271-520 of nucleolin of human 
origin) or with anti-galectin-3 monoclonal antibody (clone 9C4; a mouse 
monoclonal antibody raised against full-length human galectin-3). Then the 
immunoprecipitates were Western blotted with anti-galectin-3 and anti-nucleolin. 
We found reciprocal co-immunoprecipitation of both proteins from all studied 
subfractions (Fig. 5A). This result demonstrates that galectin-3 coexists with 
nucleolin in the same complexes in cytoplasm, on the cell surface and in the nucleus 
of human melanoma cells. 
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Fig. 5. Nucleolin interaction with endogenous galectin-3 in Ma-Mel-27 cells. A – Reciprocal 
co-immunoprecipitation of galectin-3 and nucleolin in subcellular fractions: cytosolic (1), 
membrane (2) and nuclear (3). Immunoprecipitates were electrophoresed and immunoblotted 
with anti-nucleolin or anti-galectin-3. The molecular masses (kDa) of full-length nucleolin, 
its proteolytic fragments and galectin-3 are indicated on the left-hand side of the gel. H, 
heavy chain of IgG; L, light chain of IgG. B–D – Confocal micrographs of Ma-Mel-27 cells 
double-labeled with anti-galectin-3 antibody (green) and anti-nucleolin antibody (red) in 
different subcellular locations. Arrows indicate co-localization (yellow) of galectin-3 with 
nucleolin present in (B) cytoplasm, on the cell surface (C), and in nucleoli (D). The co-
localization ratio was quantified by measuring the fluorescence intensity overlap with 
confocal software. The graphs below show the overlap of fluorescence intensity peaks 
between arrowheads in magnified views of nucleolin (red line) and lectin (green line).  
E – Negative non-specific reaction of control cells with fluorochrome-conjugated secondary 
antibodies. White open squares indicate areas magnified and shown below. 
 
Galectin-3 co-localizes with nucleolin in human melanoma cells 
To see whether endogenous galectin-3 co-localizes with nucleolin in Ma-Mel-27 
melanoma cells, we employed immunofluorescence in confocal microscopy  
(Fig. 5B-D). In agreement with our immunoaffinity purification results, we observed 
similar subcellular distributions and co-localization of galectin-3 and nucleolin in 
human melanoma cells. Nucleolin was strongly and specifically stained as large dots 
in the nucleus, indicating its nucleolar location. The results showed that the total 
pool of galectin-3 in interphase nuclei co-localized extensively with nucleolin at 
nucleolar sites (Fig. 5D). This is consistent with previous studies that found galectin-3 
in the nucleoli of different cells [4]. Both extranuclear nucleolin and galectin-3 were 
weakly to moderately positive, and more abundant in cytoplasm then on the cell 
surface, where they appeared only as occasional punctate staining (Fig. 5B and C). 
Cells not exposed to antisera recognizing nucleolin or galectin-3 showed no obvious 
fluorescence (Fig. 5E), indicating that the staining seen in cells was not due to  
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a nonspecific cross-reaction of the secondary antibody with a cell protein. The 
overlapping of intensity profiles confirmed that endogenous galectin-3 and nucleolin 
co-localize in the cytoplasm, on the cell surface and within nucleoli in melanoma 
cells. These findings were confirmed in WM1205Lu metastatic melanoma cells 




In this study, we demonstrated interrelationships between the subcellular 
localization, degradation and glycosylation of nucleolin. Nucleolin cleavage 
products have not yet been characterized fully, but several proteolytic sites have 
been mapped within the N-terminal domain of nucleolin [5]. We have shown for 
the first time differences in the proteolytic degradation pattern of nucleolin in the 
context of its subcellular localization. Several serine and threonine residues of 
nucleolin are highly phosphorylated by different kinases. Nucleolin has been 
shown to be phosphorylated by casein kinase II (CK2) during interphase [47] 
and by cell-cycle-control CDC2/Cdk1 kinase during mitosis [10]. Nucleolin is 
also a specific substrate of protein kinase C-ζ (PKC- ζ) [48], PI3K [49], and 
Rho-associated kinase (ROCK) [49]. Cell surface nucleolin is phosphorylated by 
casein kinase-like ectoprotein kinase [11]. The regulatory roles of these 
phosphorylations are not well understood. The presence of p34cdc2 phosphorylation 
sites improves the efficiency of nuclear translocation when they are 
dephosphorylated and enhances cytoplasmic localization when phosphorylated. 
These results indicate that the changes in the phosphorylation state of nucleolin 
during the cell cycle possibly are a regulatory element of nucleolin localization. 
Phosphorylation also makes nucleolin highly susceptible to proteolytic 
degradation [50]. Nucleolin fragments were produced through thiol protease 
cleavage of this molecule [51]. The differences in nucleolin degradation patterns 
are probably attributable to utilization of different phosphorylation sites by each 
of the mentioned kinases. Here, we showed that unlike membrane-bound and 
nuclear nucleolin, cytoplasmic nucleolin undergoes limited proteolysis and 
consists mainly of full-length nucleolin. This observation supports the finding 
that PRL-3 phosphatase can dephosphorylate nucleolin in the cytoplasm, 
suppressing phosphorylated nucleolin in the cytoplasm and causing 
accumulation of nucleolin in the nucleolus [52]. On the other hand, in the case of 
extranuclear nucleolin, the phosphorylation sites T105, T106 and T113 can also 
serve as glycosylation sites [36] and when they are glycosylated, they no longer 
can be phosphorylated. We cannot rule out that N- and O-glycans being in 
proximity of other phosphorylation sites may cause potential steric hindrance for 
kinases action. These may be reasons for which we found that the extranuclear 
pool of glycosylated nucleolin was a less heterogenous mixture of the full-length 
molecule and its proteolytic fragments than the nuclear pool of non-glycosylated 
protein. Therefore, we may hypothesize that the changes in the 
phosphorylation/glycosylation state of nucleolin are possibly a regulatory 
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element of the molecular mechanism responsible for its subcellular localization 
and degradation. 
We reported that cytoplasmic and membrane-bound nucleolin, unlike nuclear-
localized nucleolin, bears Tn antigen in cultured human melanoma cell line Ma-
Mel-27 [28]. Now, in a confocal microscopy approach, we used a wide spectrum 
of lectins, molecules that recognize and bind specific mono- and 
oligosaccharides, to show the localization-dependent differences in the 
glycosylation pattern of nucleolin. Unlike nucleolar nucleolin, the extranuclear 
pool of nucleolin was N- and O-glycosylated. Our observations are in agreement 
with earlier studies [36, 39, 53]. 
We found that cell surface nucleolin possesses high mannose and/or hybrid type 
N-glycans, bisected and β1-6-branched N-glycans with polylactosamine 
extension, and T antigen and α2-3/6-linked sialic acid. The cytoplasmic 
nucleolin possesses high mannose and/or hybrid type N-glycans, β1-6-branched 
N-glycans and, unlike cell surface nucleolin, core fucosylated N-glycans as well 
as Lex and H antigens. A comparison of the co-localization study with the lectin 
precipitation results reveals apparent discrepancies in relation to the AAA, LTA 
and UEA-I lectin probes. With double fluorescence staining we showed that 
only cytoplasmic nucleolin was fucosylated (Fig. 4A, AAA, LTA and UEA-I). 
Surprisingly, proteolytic fragments with molecular weights of 72, 68, 55 and 53 
kDa present in the membrane fraction but not in the cytoplasmic fraction were 
AAA-, LTA- and UEA-I-positive. These discrepancies might be explained by 
the fact that proteins from intracellular membrane vesicles (exosome, endosome, 
microsome and lysosome) are present in membrane protein fraction 2, as 
intracellular organelles remain intact after extraction of cytosol fraction 1 (Figs 
1A and 2). Cytoplasmic nucleolin is translocated to the surface through an 
unconventional secretory pathway in small secretory vesicles [29]. It has been 
suggested that fucosylation modulates the turnover of nucleolin by protecting it 
against proteolysis or autoproteolysis [37]. Our results showing differences in 
fucosylation and differences in the degree of degradation of cytoplasmic and 
membrane-bound nucleolin provide support for that suggestion. Although 
nucleolin glycosylation is absolutely required for its cell surface localization 
[53] and self-interaction [54], the consequences of this post-translational 
modification for nucleolin functioning are still unknown. As surface protein 
nucleolin serves as a receptor for various extracellular ligands involved in cell 
proliferation, differentiation, adhesion, mitogenesis and angiogenesis, it is also 
possible that glycosylation of nucleolin may be required for these interactions. 
To the best of our knowledge this report gives the first evidence that nucleolin 
interacts with galectin-3 on the cell surface, in the cytoplasm and in the 
nucleolus. Galectin-3 binds type 1 or type 2 Galβ1-3(4)GlcNAc units with 
higher affinity for polylactosamine structures. Fucosylation, sialylation or 
further modification of terminal galactose by α1-3-linked Gal or GalNAc do not 
affect binding [55]. Galectin-3 shuttles between the cytoplasm and nucleus due 
to the presence of targeting signals recognized by importin(s) and exportin-1. 
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Within the nucleus, galectin-3 can be found diffused in the nucleoplasm and 
associated within structures corresponding to subnuclear domains. The 
cytoplasmic versus nuclear distribution of galectin-3 depends on the cell type 
(normal or cancerous), the proliferative state [56], and on the presence or 
absence of an interacting partner [57]. A great number of ligands have been 
reported for galectin-3. Some of them are compartment-specific but others are 
present together with galectin-3 in both the cytoplasm and nuclear subcellular 
compartments. Here we demonstrated that this interaction also takes place in the 
cell membrane. Although galectin-3 contains a carbohydrate recognition domain 
(CRD), most proteins bind galectin-3 via protein–protein interactions. In the 
case of nuclear nucleolin these interactions are most likely to be protein–protein, 
but cytoplasmic and membrane nucleolin may also be recognized by their 
glycans. We did not perform assays in the presence of lactose, but in fact most of 
the protein–protein interactions of galectin-3 with its ligands were perturbed by 
lactose, suggesting that the binding sites overlap. The ability of galectin-3 to 
form higher order oligomers and to function as a scaffold protein promotes 
heterotypic protein interactions and provides the formation of a cluster with its 
partners. Proteins that are recruited to the cluster increase local molecular 
concentrations and thus can express their functions with higher activity, in space 
and time [58–60]. Therefore, we can hypothesize that multifaceted functions of 
nucleolin in melanoma cell proliferation and malignancy is promoted by 
recruitment of nucleolin to the galectin-3 cluster, in which, in case of 
extranuclear nucleolin, nucleolin glycan residues can fine tune galectin-3 
binding. 
We disclosed the interactions between nucleolin and galectin-3 by two methods: 
co-immunoprecipitation and co-localization. In co-immunoprecipitation, 
mediation via an intermediary molecule cannot be ruled out but the confocal 
microscopy images confirm the co-localization of these two proteins. We 
suggest that the galectin-3−nucleolin complex may participate in 
nucleologenesis. Additional studies are required to answer the question of 
whether or not this interaction is direct or indirect. The other components of the 
complexes should be investigated in future. Further work should also address the 




These results provide evidence for different paths of nucleolin degradation in the 
nucleus, in the cytoplasm, and on the cell surface. We showed that, besides the 
most representative 107-kDa form, other minor and more or less N- and  
O-glycosylated nucleolin forms coexist in the cell. Only extranuclear nucleolin 
undergoes N- and O-glycosylation. Unlike cytoplasmic nucleolin, membrane-
associated nucleolin is not fucosylated. We uncovered a potential association 
between galectin-3 and nucleolin in Ma-Mel-27 melanoma cells. Galectin-3 was 
found as a novel binding partner of nucleolin in the nucleolus, in the cytoplasm, 
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and on the cell surface of human melanoma cells. The nucleolar co-localization 
of galectin-3 with nucleolin in interphase suggests that galectin-3 may be 
involved in DNA organization and ribosome biogenesis. 
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